Verastem Inc VSTM.OQ VSTM.O is expected to show a rise in quarterly revenue when it reports results on March 12 (estimated) for the period ending December 31 2024
The Needham Massachusetts-based company is expected to report revenue of $150 thousand, according to the mean estimate from 8 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for Verastem Inc is for a loss of 81 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč
Wall Street's median 12-month price target for Verastem Inc is $13.00‚Äč, above‚Äč its last closing price of $7.00. ‚Äč‚Äč‚Äč
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.70
-0.74
-0.60
Beat
18.7
Jun. 30 2024
-0.93
-0.95
-0.31
Beat
67.5
Mar. 31 2024
-1.03
-1.00
-1.26
Missed
-26.4‚Äč
Dec. 31 2023
-0.74
-0.62
-1.02
Missed
-64.5
‚Äč‚ÄčSep. 30 2023
-0.87
-0.84
-0.75
Beat
11
Jun. 30 2023
-1.07
-1.06
-1.37
Missed
-29.2‚Äč
Mar. 31 2023
-0.96
-0.98
-0.96
Beat
2.4
Dec. 31 2022
-1.20
-1.18
-0.96
Beat
18.4
This summary was machine generated March 10 at 12:49 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)